InvestorsHub Logo

gta888

11/10/13 10:53 AM

#21272 RE: BaaBaa45 #21271

I agree then top 4 in mgmt should cut salaries in support of reducing costs then. There have been talks for years and they should have a right to buy some shares here due to valuation if nothing serious is on hand. Bp will buy only if they see sales growth. They may not if they see vascepa as a threat to statin therapy. We need a non statin related company to buy into it with a large enough sales force to complement.